fashion -WSS

fashion

author：hotspot 2025-10-02 20:48:55 - browse：1

The Senate has set its eyes on regulating insurance plans for some of the most vulnerable patients in the U.S. — the 12.5 million people eligible for both Medicare and Medicaid.

“They’re a complex group of people with a lot of chronic conditions — mental illness, frailty, disability,” said Jose Figueroa, an internal medicine physician and health policy expert at Brigham and Women’s Hospital. Over a third of these dual-eligible beneficiaries have less than a high school education, and about 90% make less than $20,000 per year.

Just around 15% of beneficiaries are eligible for both Medicare and Medicaid, but they account for a third of these programs’ spending — around $440 billion — and still don’t receive better health care, Sen. Bill Cassidy (R-La.) pointed out in a JAMA viewpoint published earlier this month. “The root cause of worse outcomes despite spending more money is a lack of coordination of care,” Cassidy wrote.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Virginia high school admissions case could be legal follow
Next article： Stigma and the return of syphilis

focus

WSS

Adam's Biotech Scorecard: Do Sarepta's exon

Stigma and the return of syphilis

Addiction doctors spar with methadone clinics over legislation

State of the Union pitch: Bigger Medicare drug price negotiations

Streamlined flu vaccines recommended by FDA advisory panel

Microsoft's Peter Lee: Generative AI could help doctors be more human

Wikipedia

fashion

hotspot

Virginia high school admissions case could be legal follow

He's 19 months old and has one of the world’s rarest diseases

United colonoscopy coverage change 'may cost lives,' doctors say

IVF doctors demand details after CooperSurgical lawsuit

United colonoscopy coverage change 'may cost lives,' doctors say

Lab trade group sues FDA to halt regulation of lab

Jerome Adams on the need for new antivirals for Covid

Gene therapies for deafness raise the question: Do deaf people want a 'cure'?

Cancer drug shortages should be causing more outrage

Fetal cell organoids grown from amniotic fluid, study finds

hotspot

Gene therapies for deafness raise the question: Do deaf people want a 'cure'?

Medicare drug price negotiation continues, as pharma counteroffers

Report: NIH

The untold story of TV’s first prescription drug ad

What will save rural psychiatry services? Higher Medicaid payments

Gene therapies for deafness raise the question: Do deaf people want a 'cure'?

leisure time

hotspot

focus

entertainment